What is PRC Clinical?
PRC Clinical operates as a premier Contract Research Organization (CRO) with over two decades of experience in delivering high-quality, customized clinical trial management services. The company specializes in U.S. clinical research, catering to a diverse range of therapeutic areas including regenerative medicine, pharmaceuticals, biologics, and biotechnology. Their comprehensive service portfolio encompasses study management, electronic Trial Master File (eTMF) and document management, study monitoring, and logistics coordination, all designed to optimize trial processes and ensure timely patient enrollment. PRC Clinical's collaborative approach with sponsors and research sites is central to its mission of achieving exceptional outcomes and facilitating clients' clinical trial objectives.
How much funding has PRC Clinical raised?
PRC Clinical has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for PRC Clinical?
The recent major strategic investment signals a pivotal moment for PRC Clinical, likely enabling accelerated growth and enhanced service offerings. With a foundation built on extensive experience and a commitment to quality, this capital will probably be directed towards expanding operational capacity, investing in advanced technological solutions for trial management, and potentially broadening its market reach within the competitive CRO landscape. The company's focus on specialized areas like regenerative medicine suggests a strategic direction towards innovation and addressing unmet needs in clinical development.
See full PRC Clinical company page
